S2k-Leitlinie Nichtinvasive Beatmung als Therapie der akuten respiratorischen Insuffizienz
Standard
S2k-Leitlinie Nichtinvasive Beatmung als Therapie der akuten respiratorischen Insuffizienz : herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin. / Westhoff, Michael; Neumann, Peter; Geiseler, Jens; Bickenbach, Johannes; Arzt, Michael; Bachmann, Martin; Braune, Stephan; Delis, Sandra; Dellweg, Dominic; Dreher, Michael; Dubb, Rolf; Fuchs, Hans; Hämäläinen, Nina; Heppner, Hans; Kluge, Stefan; Kochanek, Matthias; Lepper, Philipp M; Meyer, F Joachim; Neumann, Bernhard; Putensen, Christian; Schimandl, Dorit; Schönhofer, Bernd; Schreiter, Dierk; Walterspacher, Stephan; Windisch, Wolfram; Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI) e. V.; Deutsche Gesellschaft für Chirurgie (DGCh) e. V.; Deutsche Gesellschaft für Fachkrankenpflege und Funktionsdienste (DGF) e. V.; Deutsche Gesellschaft für Innere Medizin (DGIM) e. V.; Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin (DGIIN) e. V.; Deutsche Gesellschaft für Kardiologie (DGK) e. V.; Deutsche Gesellschaft für Neurologie (DGN) e. V.; Deutsche Gesellschaft für Neurologische Intensiv- und Notfallmedizin (DGNI) e. V.; Deutsche Gesellschaft für Palliativmedizin (DGP) e. V.; Deutsche Interdiszipläre Gesellschaft für Ausserklinische Beatmung (DIGAB) e. V.; Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI) e. V.; Gesellschaft für Neonatologie und pädiatrische Intensivmedizin (GNPI) e. V.
In: PNEUMOLOGIE, Vol. 78, No. 7, 07.2024, p. 453-514.Research output: SCORING: Contribution to journal › Guideline, recommendation, statement › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - S2k-Leitlinie Nichtinvasive Beatmung als Therapie der akuten respiratorischen Insuffizienz
T2 - herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin
AU - Westhoff, Michael
AU - Neumann, Peter
AU - Geiseler, Jens
AU - Bickenbach, Johannes
AU - Arzt, Michael
AU - Bachmann, Martin
AU - Braune, Stephan
AU - Delis, Sandra
AU - Dellweg, Dominic
AU - Dreher, Michael
AU - Dubb, Rolf
AU - Fuchs, Hans
AU - Hämäläinen, Nina
AU - Heppner, Hans
AU - Kluge, Stefan
AU - Kochanek, Matthias
AU - Lepper, Philipp M
AU - Meyer, F Joachim
AU - Neumann, Bernhard
AU - Putensen, Christian
AU - Schimandl, Dorit
AU - Schönhofer, Bernd
AU - Schreiter, Dierk
AU - Walterspacher, Stephan
AU - Windisch, Wolfram
AU - Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI) e. V.
AU - Deutsche Gesellschaft für Chirurgie (DGCh) e. V.
AU - Deutsche Gesellschaft für Fachkrankenpflege und Funktionsdienste (DGF) e. V.
AU - Deutsche Gesellschaft für Innere Medizin (DGIM) e. V.
AU - Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin (DGIIN) e. V.
AU - Deutsche Gesellschaft für Kardiologie (DGK) e. V.
AU - Deutsche Gesellschaft für Neurologie (DGN) e. V.
AU - Deutsche Gesellschaft für Neurologische Intensiv- und Notfallmedizin (DGNI) e. V.
AU - Deutsche Gesellschaft für Palliativmedizin (DGP) e. V.
AU - Deutsche Interdiszipläre Gesellschaft für Ausserklinische Beatmung (DIGAB) e. V.
AU - Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI) e. V.
AU - Gesellschaft für Neonatologie und pädiatrische Intensivmedizin (GNPI) e. V.
N1 - Thieme. All rights reserved.
PY - 2024/7
Y1 - 2024/7
N2 - The guideline update outlines the advantages as well as the limitations of NIV in the treatment of acute respiratory failure in daily clinical practice and in different indications.Non-invasive ventilation (NIV) has a high value in therapy of hypercapnic acute respiratory failure, as it significantly reduces the length of ICU stay and hospitalization as well as mortality.Patients with cardiopulmonary edema and acute respiratory failure should be treated with continuous positive airway pressure (CPAP) and oxygen in addition to necessary cardiological interventions. This should be done already prehospital and in the emergency department.In case of other forms of acute hypoxaemic respiratory failure with only mild or moderately disturbed gas exchange (PaO2/FiO2 > 150 mmHg) there is no significant advantage or disadvantage compared to high flow nasal oxygen (HFNO). In severe forms of ARDS NIV is associated with high rates of treatment failure and mortality, especially in cases with NIV-failure and delayed intubation.NIV should be used for preoxygenation before intubation. In patients at risk, NIV is recommended to reduce extubation failure. In the weaning process from invasive ventilation NIV essentially reduces the risk of reintubation in hypercapnic patients. NIV is regarded useful within palliative care for reduction of dyspnea and improving quality of life, but here in concurrence to HFNO, which is regarded as more comfortable. Meanwhile NIV is also recommended in prehospital setting, especially in hypercapnic respiratory failure and pulmonary edema.With appropriate monitoring in an intensive care unit NIV can also be successfully applied in pediatric patients with acute respiratory insufficiency.
AB - The guideline update outlines the advantages as well as the limitations of NIV in the treatment of acute respiratory failure in daily clinical practice and in different indications.Non-invasive ventilation (NIV) has a high value in therapy of hypercapnic acute respiratory failure, as it significantly reduces the length of ICU stay and hospitalization as well as mortality.Patients with cardiopulmonary edema and acute respiratory failure should be treated with continuous positive airway pressure (CPAP) and oxygen in addition to necessary cardiological interventions. This should be done already prehospital and in the emergency department.In case of other forms of acute hypoxaemic respiratory failure with only mild or moderately disturbed gas exchange (PaO2/FiO2 > 150 mmHg) there is no significant advantage or disadvantage compared to high flow nasal oxygen (HFNO). In severe forms of ARDS NIV is associated with high rates of treatment failure and mortality, especially in cases with NIV-failure and delayed intubation.NIV should be used for preoxygenation before intubation. In patients at risk, NIV is recommended to reduce extubation failure. In the weaning process from invasive ventilation NIV essentially reduces the risk of reintubation in hypercapnic patients. NIV is regarded useful within palliative care for reduction of dyspnea and improving quality of life, but here in concurrence to HFNO, which is regarded as more comfortable. Meanwhile NIV is also recommended in prehospital setting, especially in hypercapnic respiratory failure and pulmonary edema.With appropriate monitoring in an intensive care unit NIV can also be successfully applied in pediatric patients with acute respiratory insufficiency.
KW - Humans
KW - Germany
KW - Noninvasive Ventilation/standards
KW - Respiratory Insufficiency/therapy
KW - Pulmonary Medicine/standards
KW - Practice Guidelines as Topic
KW - Respiratory Distress Syndrome/therapy
KW - Acute Disease
U2 - 10.1055/a-2148-3323
DO - 10.1055/a-2148-3323
M3 - Leitlinie, Empfehlung, Stellungnahme
C2 - 37832578
VL - 78
SP - 453
EP - 514
JO - PNEUMOLOGIE
JF - PNEUMOLOGIE
SN - 0934-8387
IS - 7
ER -